Tag Archives: FDA

Posted in Social Media on July 9th, 2009 by Mark Hollander

Adverse Event Reporting & Appropriate Dialogue in Social Media for Health Care

Social Media guru Jonathan Richman and author of Dose of Digital blog, writes there is a Myth of Adverse Event Reporting in pharma marketing.  Drawing upon a Nielsen Study which found that only 1 in 500 postings on the Yahoo Health discussion boards met the full criteria for adverse event reporting, pharma may in fact be over-sensitized to the issue.

Do AER staffing requirements prevent social media dialogue?

Assuming that the Nielsen study is statistically significant (is a sample size of 500 read more…

4 Comments

Posted in Medical-Education on July 2nd, 2009 by Mark Hollander

More than half of American adults look online for health information.

pew internet and american life project logo

What this means for your digital marketing initiatives

The Pew Internet & American Life Project reports that 61% of American adults look online for health information and continue to deepen their engagement with the online world.

41% of e-patients have read someone else’s commentary or experience about health or medical issues on an online news group, website, or blog.
24% of e-patients have consulted rankings or reviews online of doctors or other providers.
24% of e-patients have consulted rankings or reviews online of hospitals or read more…

Comments Off

Posted in Social Media on June 24th, 2009 by Mark Hollander

Are Branded Pharma Tweets Banal?

ePharma Pioneer Club on Facebook

John Mack of  the Pharma Marketing Blog hosted a fascinating, by invitation only conference call today to discuss the first-ever pharma branded Tweet for Novo Nordisk’s Levemir™.  Never one to mince words, Mack suggested in the invitation that:

Novo Nordisk’s Branded (Levemir) Tweet is Sleazy Twitter Spam!
Novo Nordisk Selectively Copies & Edits Kimball’s Tweets

With such a provocative invitation you can imagine that the call consisted almost entirely of health care advertising, public relations and promotions agencies. Until each of the speakers read more…

Comments Off

Posted in Mobile Video on May 20th, 2009 by Mark Hollander

FDA Owes Health Care Marketers Better Guidelines for Online Media

The Wall Street Journal Health Blog

It’s not easy for a health care marketer making the leap from broadcast to broadband.  As reported by Jacob Goldstein in the Wall Street Journal’s Health Blog,  Johnson & Johnson received an FDA warning letter which prompted the removal of an online video for Ultram ER from the PainAwareness.org site.

What strikes me as interesting is that PainAwareness is a site intended for health care practitioners and goes so far as to offer CME.  Would this have been different had the read more…

Comments Off